JPMorgan Chase & Co. filings document a bank holding company with worldwide financial services operations and multiple classes of exchange-listed securities. Periodic reports describe investment banking, consumer and small-business financial services, commercial banking, transaction processing and asset management, along with capital, assets and stockholders’ equity disclosures.
The company’s 8-K filings record material events and identify registered securities including JPM common stock, depositary shares representing fractional interests in non-cumulative preferred stock, and guarantees of notes and exchange-traded notes issued by JPMorgan Chase Financial Company LLC. Proxy materials cover board matters, executive compensation, equity awards, shareholder voting items and other governance disclosures.
A notice under Rule 144 reports a planned sale of 3,487 shares of common stock, with an aggregate market value of $1,090,727.70. The securities are expected to be sold on the NYSE through J.P. Morgan Securities LLC, located at 270 Park Avenue, New York, NY 10017-2014, with an approximate sale date of 01/16/2026.
The shares being sold were acquired on 01/13/2026 as a result of awards granted by the issuer and are described as equity compensation for common stock with $1 par value. The form also includes a representation that the person for whose account the securities are to be sold does not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
JPMorgan Chase & Co. (symbol JPM) has a planned insider sale of common stock under Rule 144. A holder has filed to sell 5,732 shares of JPM common stock through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 01/16/2026 and an aggregate market value of $1,792,878.56. The filing states that these 5,732 shares of common stock with $1 par value were acquired on 01/13/2026 as equity compensation from the issuer.
A holder of JPM common stock has filed a notice of proposed sale under Rule 144. The filing covers 3,908 shares of common stock to be sold through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of 1222353.41. The issuer had 2,696,272,576 shares outstanding when the notice was prepared, which is a baseline figure. These shares were originally acquired on 01/13/2022 as equity compensation awards from the issuer, with payment also dated 01/13/2022 and described as Equity Compensation.
JPM has filed a notice of proposed sale under Rule 144 for 2,047 shares of common stock, to be sold through J.P. Morgan Securities LLC on the NYSE around 01/16/2026. The filing shows an aggregate market value of $640,295.04 for these shares and notes that 2,696,272,576 shares of the same class were outstanding. The shares to be sold were acquired on 01/13/2026 as equity compensation awards from the issuer, paid in stock rather than cash.
By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
A shareholder has filed a Form 144 notice for the planned sale of 8,571 shares of common stock. The shares are expected to be sold on or about 01/16/2026 on the NYSE through J.P. Morgan Securities LLC, with an indicated aggregate market value of $2,680,888.09. The issuer has 2,696,272,576 shares outstanding.
The securities being sold were acquired on 01/13/2026 from the issuer as equity compensation in the form of awards granted by the issuer. By signing the notice, the selling person represents that they are not aware of any material adverse, non-public information about the issuer’s current or prospective operations.
JPM has a planned sale of 7,364 shares of common stock under Rule 144 through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 01/16/2026. The filing reports an aggregate market value of these shares of $2,303,393.28 and notes that 2,696,272,576 shares of this class were outstanding.
The shares to be sold were acquired on 01/13/2026 as equity compensation awards granted by the issuer, with the consideration described as Equity Compensation.
JPMorgan Chase & Co. corporate controller Elena A. Korablina reported multiple equity transactions involving company stock and restricted stock units. On January 13, 2026, several batches of restricted stock units (RSUs) were converted to common stock at an exercise price of $0.0000, resulting in acquisitions of 6,017, 5,788, 1,541, and 1,400 shares of JPMorgan Chase common stock. Each RSU represents a contingent right to receive one share of common stock, with grants structured to vest in scheduled installments and, for certain grants, subject to 12‑month post‑vesting holding periods for identified risk-taking staff.
On the same date, 7,782 shares of common stock were disposed of at a price of $318.715 per share in a transaction coded "F," indicating shares withheld to cover tax obligations related to the vesting. After these transactions, Korablina directly beneficially owned 20,036 shares of JPMorgan Chase common stock and continued to hold RSUs that vest through January 13, 2027.
JPMorgan Chase & Co. executive Troy L. Rohrbaugh, Co-CEO of the Corporate & Investment Bank, reported multiple equity transactions dated January 13, 2026. He converted 22,706 and 20,082 Restricted Stock Units (RSUs) into an equal number of shares of JPMorgan common stock at an exercise price of $0 per share, reflecting the vesting of previously granted RSUs. Following these transactions, his directly held common stock position shown in the table includes 161,279 shares, plus 91.8346 shares held indirectly through a 401(k) plan.
The filing also reports a disposition of 23,135 shares of common stock at a price of $318.715 per share under transaction code “F”, indicating shares withheld to cover tax obligations. Footnotes explain that each RSU represents a contingent right to one share of common stock and that the RSU grants vest in two equal annual installments on January 13, 2025 and 2026, and on January 13, 2026 and 2027, respectively.
JPMorgan Chase & Co. Chief Operating Officer Jennifer Piepszak reported multiple equity transactions involving company stock. On January 13, 2026, she converted 17,898 and 16,020 Restricted Stock Units (RSUs) into an equal number of JPMorgan common shares at an exercise price of $0 per share, reflecting previously granted equity awards settling in stock. The filing shows a separate transaction the same day in which 16,775 common shares were disposed of at $318.715 per share under code “F,” indicating shares were withheld to cover taxes.
After these transactions, Piepszak directly beneficially owned 79,598 shares of JPMorgan common stock and 16,021 RSUs. Each RSU represents a contingent right to receive one share of JPMorgan common stock, with the awards vesting in 50% increments on specified dates in 2025, 2026, and 2027.
JPMorgan Chase & Co. executive Douglas B. Petno, Co-CEO of the Corporate & Investment Bank, reported equity award activity and related stock transactions. On January 13, 2026, he converted 15,761 restricted stock units and another 14,215 restricted stock units into the same number of JPMorgan common shares at an exercise price of $0.00 per share.
On the same date, there was a disposition of 16,027 shares of common stock at a price of $318.715 per share. Following these transactions, he held 372,613 shares of JPMorgan common stock directly. In addition, 70,457 shares of common stock were reported as held indirectly through family trusts.